Patent · US Active

Activation assay for the diagnosis of a heparin-induced thrombocytopenia

US11262357B2 · kind B2 · utility

0Cited by
4References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 8, 2018
Grant dateMar 1, 2022
Priority date
Expiry dateFeb 14, 2039

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/226
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to a functional, easily automatable assay for establishing a heparin-induced thrombocytopenia (HIT). What is measured is the secretion of PF4 (platelet factor 4) from activated thrombocytes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.